UCB SA (UCBJY)
OTCMKTS
· Delayed Price · Currency is USD
89.22
+0.12 (0.13%)
Mar 28, 2025, 4:00 PM EST
UCB SA Employees
As of December 31, 2024, UCB SA had 9,378 total employees, including 9,052 full-time and 326 part-time employees. The number of employees increased by 295 or 3.25% compared to the previous year.
Employees
9,378
Change (1Y)
295
Growth (1Y)
3.25%
Revenue / Employee
$691,176
Profits / Employee
$119,653
Market Cap
33.83B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
UCB SA News
- 24 days ago - Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders - Benzinga
- 24 days ago - BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden - Benzinga
- 27 days ago - UCB SA (UCBJF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 27 days ago - Full Year 2024 Ucb SA Earnings Call Transcript - GuruFocus
- 4 weeks ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 2 months ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 2 months ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga